X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3402) 3402
Publication (405) 405
Book Review (67) 67
Book Chapter (47) 47
Dissertation (10) 10
Book / eBook (8) 8
Government Document (7) 7
Conference Proceeding (6) 6
Data Set (4) 4
Newspaper Article (3) 3
Magazine Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2082) 2082
index medicus (2008) 2008
angiogenesis (1576) 1576
antiangiogenic therapy (1510) 1510
oncology (1368) 1368
animals (1310) 1310
cancer (1297) 1297
female (839) 839
endothelial growth-factor (799) 799
tumors (763) 763
mice (747) 747
vascular endothelial growth factor (743) 743
angiogenesis inhibitors - therapeutic use (702) 702
bevacizumab (641) 641
male (634) 634
antiangiogenics (616) 616
chemotherapy (569) 569
metastasis (499) 499
angiogenesis inhibitors - pharmacology (495) 495
neovascularization, pathologic - drug therapy (468) 468
cell line, tumor (445) 445
care and treatment (419) 419
antiangiogenic agents (413) 413
pharmacology & pharmacy (413) 413
antineoplastic agents (375) 375
antimitotic agents (360) 360
antineoplastic agents - therapeutic use (356) 356
research (350) 350
neoplasms - drug therapy (346) 346
therapy (344) 344
tumor angiogenesis (343) 343
middle aged (337) 337
health aspects (335) 335
vegf (327) 327
analysis (322) 322
in-vivo (321) 321
apoptosis (317) 317
cancer therapies (314) 314
adult (313) 313
expression (306) 306
growth (303) 303
aged (299) 299
treatment outcome (292) 292
medicine (270) 270
inhibition (266) 266
angiogenesis inhibitors (263) 263
endothelial cells (263) 263
antineoplastic agents - pharmacology (261) 261
research article (258) 258
antiangiogenic (253) 253
neovascularization (251) 251
mice, nude (250) 250
neoplasms - blood supply (249) 249
hypoxia (239) 239
xenograft model antitumor assays (239) 239
medicine & public health (235) 235
cell biology (232) 232
article (229) 229
cells (228) 228
cell proliferation - drug effects (227) 227
multidisciplinary sciences (224) 224
drug therapy (219) 219
antiangiogenic activity (218) 218
biochemistry & molecular biology (214) 214
survival (214) 214
breast-cancer (213) 213
neovascularization, pathologic - pathology (213) 213
clinical trials (212) 212
proteins (212) 212
angiogenesis inhibitors - administration & dosage (207) 207
kinases (206) 206
tumor-growth (206) 206
metastases (201) 201
vascular endothelial growth factor a - metabolism (198) 198
breast cancer (197) 197
science (195) 195
biology (193) 193
medicine, research & experimental (192) 192
radiology, nuclear medicine & medical imaging (191) 191
solid tumors (191) 191
endothelium (187) 187
antineoplastic combined chemotherapy protocols - therapeutic use (181) 181
in-vitro (181) 181
neoplasms - pathology (177) 177
toxicity (177) 177
glioblastoma (175) 175
magnetic resonance imaging (174) 174
patients (174) 174
physiological aspects (171) 171
vascular endothelial growth factor a - antagonists & inhibitors (171) 171
growth factors (169) 169
neovascularization, pathologic - metabolism (168) 168
development and progression (167) 167
drugs (167) 167
cell proliferation (165) 165
phase-ii trial (164) 164
medical research (163) 163
gene expression (162) 162
chemistry, medicinal (160) 160
studies (160) 160
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3376) 3376
French (66) 66
Japanese (19) 19
German (12) 12
Spanish (9) 9
Polish (7) 7
Chinese (6) 6
Korean (2) 2
Arabic (1) 1
Hungarian (1) 1
Portuguese (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2006, ISBN 9780470012949, xvii, 350 p., [8] p. of plates
Book
Bioorganic & Medicinal Chemistry, ISSN 0968-0896, 01/2017, Volume 25, Issue 2, pp. 545 - 556
The utility of cytostatic antiangiogenic agents (AA) in cancer chemotherapy lies in their combination with cytotoxic chemotherapeutic agents. Clinical... 
Receptor tyrosine kinase inhibitors | Microtubule targeting agents | Combination chemotherapy | Antiangiogenic | Multitargeted agents | CHEMISTRY, MEDICINAL | BIOCHEMISTRY & MOLECULAR BIOLOGY | CHEMISTRY, ORGANIC | DRUG-RESISTANCE | TUMOR HETEROGENEITY | CELL LUNG-CANCER | BREAST-CANCER | COLCHICINE SITE | BIOLOGICAL EVALUATION | ANGIOGENESIS INHIBITOR | ANTIANGIOGENIC AGENTS | RECEPTOR TYROSINE KINASE | ENDOTHELIAL GROWTH-FACTOR | Pyrimidines - chemical synthesis | Antineoplastic Agents - chemical synthesis | Humans | Structure-Activity Relationship | Pyrimidines - chemistry | Dose-Response Relationship, Drug | Protein Kinase Inhibitors - chemistry | Microtubules - drug effects | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Antineoplastic Agents - pharmacology | Molecular Structure | Angiogenesis Inhibitors - chemical synthesis | Cell Line | Protein Kinase Inhibitors - chemical synthesis | Angiogenesis Inhibitors - pharmacology | Pyrimidines - pharmacology | Antineoplastic Agents - chemistry | Receptor Protein-Tyrosine Kinases - metabolism | Drug Discovery | Pyrroles - pharmacology | Pyrroles - chemical synthesis | Neovascularization, Pathologic - drug therapy | Pyrroles - chemistry | Cell Proliferation - drug effects | Molecular Docking Simulation | Protein Kinase Inhibitors - pharmacology | Angiogenesis Inhibitors - chemistry | Drug Screening Assays, Antitumor | Antimitotic agents | Amines | Antineoplastic agents | Analysis | receptor tyrosine kinase inhibitors | multitargeted agents | microtubule targeting agents | antiangiogenic | combination chemotherapy
Journal Article
2009, ISBN 1402095635, ix, 125
In 1971, J. Folkman hypothesized that tumor growth is angiogenesis-dependent. In 2004, the FDA approved the first angiogenesis inhibitor. This book compiles... 
Neovascularization | Blood-vessels | Growth | Neovascularization inhibitors | Tumors | Clinical & internal medicine | Treatment | Pathology | History of Science | Biomedicine | Cancer Research | Oncology | Biomedicine general | Cell Biology
Book
2010, Recent results in cancer research, ISBN 9783540782803, Volume 180., xiv, 231
All aspects from the bench to the bedside are considered in this examination of the latest developments in angiogenesis inhibition in cancer. The authors pay... 
Neovascularization inhibitors | Clinical & internal medicine | Chemotherapy | Therapeutic use | Cancer | Oncology | Cancer Research | Medicine & Public Health | Hematology
Book
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 5/2013, Volume 71, Issue 5, pp. 1147 - 1157
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 01/2018, Volume 24, Issue 1, pp. 169 - 180
Journal Article